Safety and Effectiveness of Microfocused Ultrasound With Visualization for the Correction of Moderate to Severe Atrophic Acne Scars
Maas, C.S..; Joseph, J.H..
Journal of Drugs in Dermatology Jdd 18(11): 1109-1114
2019
ISSN/ISBN: 1545-9616 PMID: 31741353 Document Number: 17976
Objective: To assess the effectiveness of microfocused ultrasound with visualization (MFU-V) for treating moderate to severe atrophic acne scars.
Document emailed within 1 workday
Related Documents
Casabona, G. 2018: Combined use of microfocused ultrasound and a calcium hydroxylapatite dermal filler for treating atrophic acne scars: A pilot study Journal of Cosmetic and Laser Therapy 20(5): 301-306Schlessinger, J.; Lupin, M.; McDaniel, D.; George, R. 2019: Safety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic Rosacea Journal of Drugs in Dermatology: Jdd 18(6): 522
Schweiger, E.S.; Sundick, L. 2013: Focal Acne Scar Treatment (FAST), a new approach to atrophic acne scars: a case series Journal of Drugs in Dermatology: Jdd 12(10): 1163-1167
Fabi, S.G..; Joseph, J.; Sevi, J.; Green, J.B..; Peterson, J.Deaver. 2019: Optimizing Patient Outcomes by Customizing Treatment With Microfocused Ultrasound With Visualization: Gold Standard Consensus Guidelines from an Expert Panel Journal of drugs in dermatology: JDD 18(5): 426-432
Tan, J.; Bourdès, V.ér.; Bissonnette, R.; Petit B Eng, L.; Reynier, P.; Khammari, A.; Dreno, B. 2017: Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular Erythema Journal of Drugs in Dermatology: Jdd 16(6): 566-572
Epstein, R.E.; Spencer, J.M. 2010: Correction of atrophic scars with artefill: an open-label pilot study Journal of Drugs in Dermatology: Jdd 9(9): 1062-1064
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740
Cracco, C.; Stella, M.; Teich Alasia, S.; Filogamo, G. 1992: Comparative study of Langerhans cells in normal and pathological human scars. I. Atrophic scars European Journal of Histochemistry: Ejh 36(1): 41-52
Eichenfield, L.F.; Draelos, Z.; Lucky, A.W.; Hebert, A.A.; Sugarman, J.; Stein Gold, L.; Rudisill, D.; Liu, H.; Manna, V. 2013: Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides Journal of Drugs in Dermatology: Jdd 12(6): 611-618
Isarría, M.ía.J.é; Cornejo, P.; Muñoz, E.ía.; Royo de la Torre, J.; Moraga, J.M. 2011: Evaluation of clinical improvement in acne scars and active acne in patients treated with the 1540-nm non-ablative fractional laser Journal of Drugs in Dermatology: Jdd 10(8): 907-912
Tanghetti, E.; Dhawan, S.; Green, L.; Del Rosso, J.; Draelos, Z.; Leyden, J.; Shalita, A.; Glaser, D.A.; Grimes, P.; Webster, G.; Barnett, P.; Le Gall, N. 2010: Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris Journal of Drugs in Dermatology: Jdd 9(5): 549-558
Goldman, M.P.; Boyce, S.M. 2003: A single-center study of aminolevulinic acid and 417 NM photodynamic therapy in the treatment of moderate to severe acne vulgaris Journal of Drugs in Dermatology: Jdd 2(4): 393-396
Stein Gold, L.; Pariser, D.M..; Guenin, E. 2019: Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability Journal of Drugs in Dermatology: Jdd 18(12): 1218-1225
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Jensen, J.Daniel.; Huynh, T.; Cafardi, J.; Sami, N. 2013: Resident Rounds. Part III A. Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: a two-case series Journal of drugs in dermatology: JDD 12(6): 710-711
Webster, G.; Rich, P.; Gold, M.H.; Mraz, S.; Calvarese, B.; Chen, D. 2009: Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations Journal of Drugs in Dermatology: Jdd 8(8): 736-743
Eichenfield, L.F.; Krakowski, A.C. 2012: Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel Journal of Drugs in Dermatology: Jdd 11(7): 818-824
Leyden, J.J.; Bruce, S.; Lee, C.S.; Ling, M.; Sheth, P.B.; Stewart, D.M.; Werschler, W.P.; Gilbert, R.D.; Kircik, L. 2013: A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium Journal of Drugs in Dermatology: Jdd 12(6): 658-663
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Alexiades, M. 2015: Randomized, Double-Blind, Split-Face Study Evaluating Fractional Ablative Erbium:YAG Laser-Mediated Trans-Epidermal Delivery of Cosmetic Actives and a Novel Acoustic Pressure Wave Ultrasound Technology for the Treatment of Skin Aging, Melasma, and Acne Scars Journal of Drugs in Dermatology: Jdd 14(11): 1191-1198